Zepto® has been demonstrated in a FDA clinical trial to be safe and effective.  No change in corneal incision size was observed after Zepto use in 70% of cases, and a mean enlargement of 30 micron was encountered in 30% of cases.  No differences in ocular condition have been observed after Zepto use compared to CCC, with a peak temperature increase of 1-2°C for a fraction of a second.

View Miyake-Apple Imaging of Zonular Tissue During Zepto Use

View Temperature Testing and Data Sheet

Download Peer Reviewed Publication of Zepto Capsulotomy Strength Testing

Download Peer Reviewed Publication with Zepto Product Performance Review

NEWS

15 Mar Mynosys Welcomes Mediconsult as Zepto Distributor in Switzerland We are pleased to share the news that our partner in Switzerland for ... read more ›
15 Mar Teleon Surgical Joins Zepto Team as Distributor for Germany Mynosys Cellular Devices is pleased to partner with Teleon Surgical ... read more ›
22 Feb Visual Axis Centration JCRS Article Wins Highly Regarded Rosen Award We are very excited to share the news that the JCRS May 2018 article ... read more ›

FEATURED VIDEO